Cologuard and Medicare coverage (2014)
Exact Sciences won FDA approval for Cologuard, a stool-based colon cancer test, in August 2014. A Medicare coverage decision followed, giving the test a payer pathway.
Cologuard became Exact Sciences' core product.
It showed that a noninvasive diagnostic can scale once Medicare pays for it.
EsoGuard is trying to make the same jump from test to reimbursed product.
